Ann Arbor、MIにおける大腸癌の臨床試験
Ann Arborとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
被験者募集中
- University of Michigan Health, Ann Arbor
Family Communications After Genetic Testing
被験者募集中健康なボランティア歓迎
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- 他4件
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
被験者募集中第2相
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- Chelsea Hospital, Chelsea · 15マイル先
- 他3件
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7マイル先
- 他4件
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
被験者募集中第1/2相
- University of Michigan, Ann Arbor
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第2相
- University Of Michigan /ID# 270790, Ann Arbor
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
被験者募集中第3相
- University of Michigan Rogel Cancer Center, Ann Arbor
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
被験者募集中第1/2相
- University of Michigan Health System, Ann Arbor
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
被験者募集中第3相
- VA Ann Arbor Healthcare System, Ann Arbor
- University of Michigan, Ann Arbor
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- University of Michigan, Ann Arbor
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
被験者募集中第3相
- University of Michigan Rogel Cancer Center, Ann Arbor
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
被験者募集中第2/3相
- Local Institution - 0430, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
被験者募集中第1/2相
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
被験者募集中第1相
- University of Michigan Rogel Cancer Center, Ann Arbor
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
被験者募集中第1/2相
- C S Mott Children's Hospital, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
被験者募集中第2相
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
被験者募集中第1/2相
- University of Michigan, Ann Arbor
FITting Non-invasive Tests in Lynch Syndrome Surveillance
被験者募集中観察研究
- University of Michigan, Ann Arbor
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
被験者募集中第3相健康なボランティア歓迎
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7マイル先
- 他5件
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
被験者募集中
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
被験者募集中観察研究
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology -Ann Arbor, Ypsilanti · 7マイル先
- Chelsea Hospital, Chelsea · 15マイル先
- 他3件
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY78件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Philadelphia, PA44件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA37件の研究
- Chicago, IL34件の研究
Ann Arborにおける他の研究
- 乳がん27件の研究
- 前立腺がん27件の研究
- 非小細胞肺癌26件の研究
- がん（全種類）25件の研究
- 肺がん23件の研究
- 心不全22件の研究
- 急性骨髄性白血病17件の研究
- 心血管疾患16件の研究
- 膵臓がん14件の研究
- 悪性黒色腫12件の研究
- 脳卒中12件の研究
- 頭頸部扁平上皮癌12件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。